Clinical Trial Update: Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of VX-548 for acute postoperative pain after bunionectomy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• VX-548

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Acute Pain | Phase 3 | Status: COMPLETED | Results posted: 2025-08-01